Skip to content
FIND A HEALTH VALLEY ACTOR

Using proteins as barcodes to fight against counterfeiting

Nano Decoder

Nanodecoder, an EPFL spin-off, receives CHF 100 000 from FIT   The Fondation pour l’Innovation Technologique selection committee announced they have made an Innogrant award of CHF 100 000 to NanoDecoder – an EPFL-based project developing nanopore sensing technologies to fight conterfeiting and perform molecular diagnostics. The startup is working on engineered bio-nanopore providing fast…

Read More

Nestlé Health Science invests EUR 40 million in Enterome

Nestlé - Enterome

Nestlé Health Science has signed a collaboration agreement with French company Enterome to target food allergies and chronic intestinal diseases   Enterome develops new treatments for cancer and autoimmune diseases based on its unique knowledge of the microbiota. With Nestlé Health Science, the french company intends to work on the development of an experimental treatment,…

Read More

ADC Therapeutics signs multi-million dollar licensing agreement with Sobi

ADC Therapeutics

The swiss and the Swedish companies partner for the development and commercialization of ZYNLONTA®, a drug for hematologic and solid tumors   ADC Therapeutics SA has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (Sobi®) for the development and commercialization of ZYNLONTA® for all hematologic and solid tumor indications outside of the…

Read More

Gnubiotics gets a CHF 1.4 million Innosuisse Grant

Gnubiotics

The biotech company evaluates the effects of glycopeptides on solid tumors   Gnubiotics Sciences, a biotech company pioneering the discovery and development of immunomodulatory glycopeptides based in Biopôle, announced that the Swiss Innovation Agency (Innosuisse) will support a research collaboration with the University Hospital Zürich to accelerate the development of Gnubiotics’ GLAAD technology in a…

Read More

ten23health is building a new facility in Visp

ten23health

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a former Swissfillon site to install its production facility. In March 2022, a first 1,000 m2 expansion was announced. The new 5,000 m2 facility will include sterile manufacturing lines plus laboratories, offices and technical areas across…

Read More

Ecotope, the new EPFL Innovation Park’s project

Ecotope 1

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together startups, researchers and outside companies. The Canton of Vaud is the project’s main partner.   The EPFL Innovation Park is already home to over 150 startups and 30 large companies employing over 2,600 people. In…

Read More

A CHF 12 Million Innosuisse Grant for a VR Surgical Training Method

ORama VR

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A. is a full partner, with a total of CHF 12 million over the next four years.   The project initiates a paradigm shift in practical training in surgery: Away from primary training in the operating…

Read More

AlveoliX wins the Swiss Medtech Award 2022

AlveoliX Swiss Medtech Award

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019, has created a small-scale replica of the human lung called «Lung-on-Chip» that can also mimic respiratory motions. According to the jury, this organ-on-chip technology has the potential to establish itself as the new standard in…

Read More

BioAlps at OM Pharma

BioAlps OM Pharma 4à6

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma in Geneva.   OM Pharma is a leader in the prevention of recurrent respiratory and urinary tract infections with products regulating the immune system based on oral bacterial extracts. Broncho-Vaxom® and Uro Vaxom® are marketed…

Read More

Pr. Antoine Geissbuhler is the new BioAlps’ President

Prof. Antoine Geissbuhler BioAlps President

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster in Europe   After a selection process of several months, BioAlps’ Executive Committee identified a strong candidate to take over the role of Mr Claude Clément as President of the BioAlps Association. On Thursday 19…

Read More